Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions https://cyrusgihs019604.wikitidings.com/6951046/promising_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment